神経補綴の世界市場：洞察、競合情勢、市場予測：2030年

神経補綴の市場規模は、2023年に71億4,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に12.75％のCAGRで拡大し、2030年には146億4,000万米ドルに達すると予測されています。神経補綴の需要は主に、神経疾患や神経損傷の有病率の上昇、難聴や視力低下に悩む患者の増加によるものです。主要企業間の研究開発活動や先進機器開発のための協力関係の発展が、2024年から2030年までの予測期間における神経補綴市場のプラス成長に寄与する主な要因となっています。

神経障害や神経損傷の有病率の上昇は、神経補綴市場の大幅な成長を促進する見通しです。世界保健機関（WHO）が2024年4月に発表したデータによると、2021年には世界で約1,540万人が脊髄損傷を患いました。同様に、米国脊髄協会（United Spinal Association）は2022年、米国では年間約17,700人が脊髄損傷と診断されていると報告しています。筋肉や神経を刺激することで運動機能を回復させる神経補綴は、このような損傷に見舞われた人々にとって極めて重要なものとなっています。神経疾患、特に脊髄損傷の発生率が上昇するにつれて、神経補綴ソリューションに対する需要も増加し、市場の拡大が加速しています。

筋萎縮性側索硬化症（ALS）や脊髄性筋萎縮症などの運動ニューロン障害、アルツハイマー病やパーキンソン病などの認知障害の発生が増加しており、市場の成長をさらに押し上げると予想されます。WHOが2023年に発表した推計によると、世界中で約5,500万人が認知症を患っており、毎年1,000万人近くの新規患者が報告されています。認知症の最も一般的な形態であるアルツハイマー病は、これらの症例の60～70％を占めています。運動ニューロン障害の患者数は増加の一途をたどっており、神経補綴のニーズは急増すると予測され、予測期間中に市場の大幅な進歩が見込まれます。

さらに、神経補綴の需要は、聴覚障害や視覚障害などの感覚障害にも及んでいます。2023年3月のWHOのデータによると、欧州では1億9,000万人以上が難聴の影響を受けており、この数は2050年までに2億3,000万人を超えると予想されています。神経補綴の代表的なタイプである人工内耳は、内耳の損傷部分をバイパスして聴神経を直接刺激することで、重度の感音難聴者の聴力を回復させるという重要な役割を担っています。聴覚と視覚の障害がより一般的になるにつれ、神経補綴市場は力強い成長が見込まれます。

当レポートでは、世界の神経補綴市場について調査し、市場の概要とともに、タイプ別、手技別、技術別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 神経補綴市場レポートのイントロダクション

第2章 神経補綴市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 神経補綴市場の主な要因分析

• 神経補綴の市場促進要因
• 神経補綴の市場抑制要因と課題
• 神経補綴の市場機会

第6章 神経補綴市場におけるポーターのファイブフォース分析

第7章 神経補綴市場の評価

• タイプ別
• 手技別
• 技術別
• エンドユーザー別
• 地域別

第8章 神経補綴市場の企業と製品プロファイル

• Medtronic
• Boston Scientific Corporation
• Abbott Laboratories
• NeuroPace, Inc.
• Cochlear Ltd.
• Sonova
• NeuroSigma, Inc.
• Blackrock Neurotech
• Synchron
• LivaNova, Inc.
• MED-EL Medical Electronics
• BrainGate
• NEVRO CORP.
• Terumo Corporation
• Penumbra, Inc.
• BrainCo, Inc.
• Axoft Inc.
• Demant A/S
• Synapse Biomedical Inc.
• Cognixion, Inc.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Neuroprosthetics Market in Global (2021-2030)
• Table 3: Neuroprosthetics Market in Global by Type (2021-2030)
• Table 4: Neuroprosthetics Market in Global by Procedure (2021-2030)
• Table 5: Neuroprosthetics Market in Global by Technology (2021-2030)
• Table 6: Neuroprosthetics Market in Global by End-User (2021-2030)
• Table 7: Neuroprosthetics Market in Global by Geography (2021-2030)
• Table 8: Neuroprosthetics Market in North America (2021-2030)
• Table 9: Neuroprosthetics Market in the United States (2021-2030)
• Table 10: Neuroprosthetics Market in Canada (2021-2030)
• Table 11: Neuroprosthetics Market in Mexico (2021-2030)
• Table 12: Neuroprosthetics Market in Europe (2021-2030)
• Table 13: Neuroprosthetics Market in France (2021-2030)
• Table 14: Neuroprosthetics Market in Germany (2021-2030)
• Table 15: Neuroprosthetics Market in United Kingdom (2021-2030)
• Table 16: Neuroprosthetics Market in Italy (2021-2030)
• Table 17: Neuroprosthetics Market in Spain (2021-2030)
• Table 18: Neuroprosthetics Market in the Rest of Europe (2021-2030)
• Table 19: Neuroprosthetics Market in Asia-Pacific (2021-2030)
• Table 20: Neuroprosthetics Market in China (2021-2030)
• Table 21: Neuroprosthetics Market in Japan (2021-2030)
• Table 22: Neuroprosthetics Market in India (2021-2030)
• Table 23: Neuroprosthetics Market in Australia (2021-2030)
• Table 24: Neuroprosthetics Market in South Korea (2021-2030)
• Table 25: Neuroprosthetics Market in Rest of Asia-Pacific (2021-2030)
• Table 26: Neuroprosthetics Market in the Rest of the World (2021-2030)
• Table 27: Neuroprosthetics Market in the Middle East (2021-2030)
• Table 28: Neuroprosthetics Market in Africa (2021-2030)
• Table 29: Neuroprosthetics Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Neuroprosthetics Market in Global (2021-2030)
• Figure 3: Neuroprosthetics Market in Global by Type (2021-2030)
• Figure 4: Neuroprosthetics Market in Global by Procedure (2021-2030)
• Figure 5: Neuroprosthetics Market in Global by Technology (2021-2030)
• Figure 6: Neuroprosthetics Market in Global by End-User (2021-2030)
• Figure 7: Neuroprosthetics Market in Global by Geography (2021-2030)
• Figure 8: Neuroprosthetics Market in North America (2021-2030)
• Figure 9: Neuroprosthetics Market in the United States (2021-2030)
• Figure 10: Neuroprosthetics Market in Canada (2021-2030)
• Figure 11: Neuroprosthetics Market in Mexico (2021-2030)
• Figure 12: Neuroprosthetics Market in Europe (2021-2030)
• Figure 13: Neuroprosthetics Market in France (2021-2030)
• Figure 14: Neuroprosthetics Market in Germany (2021-2030)
• Figure 15: Neuroprosthetics Market in United Kingdom (2021-2030)
• Figure 16: Neuroprosthetics Market in Italy (2021-2030)
• Figure 17: Neuroprosthetics Market in Spain (2021-2030)
• Figure 18: Neuroprosthetics Market in the Rest of Europe (2021-2030)
• Figure 19: Neuroprosthetics Market in Asia-Pacific (2021-2030)
• Figure 20: Neuroprosthetics Market in China (2021-2030)
• Figure 21: Neuroprosthetics Market in Japan (2021-2030)
• Figure 22: Neuroprosthetics Market in India (2021-2030)
• Figure 23: Neuroprosthetics Market in Australia (2021-2030)
• Figure 24: Neuroprosthetics Market in South Korea (2021-2030)
• Figure 25: Neuroprosthetics Market in Rest of Asia-Pacific (2021-2030)
• Figure 26: Neuroprosthetics Market in the Rest of the World (2021-2030)
• Figure 27: Neuroprosthetics Market in the Middle East (2021-2030)
• Figure 28: Neuroprosthetics Market in Africa (2021-2030)
• Figure 29: Neuroprosthetics Market in South America (2021-2030)
• Figure 30: Market Drivers
• Figure 31: Market Barriers
• Figure 32: Marker Opportunities
• Figure 33: PORTER'S Five Force Analysis

Neuroprosthetics Market by Type (Motor Prosthetics, Cognitive Prosthetics, Auditory Prosthetics/Cochlear Implants, and Visual Prosthetics/Retinal Implants), Procedure (Invasive and Non-Invasive), Technology (Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing the growing prevalence of neurological disorders and increasing R&D activities and collaborations to develop advanced devices.

The neuroprosthetics market was valued at USD 7.14 billion in 2023, growing at a CAGR of 12.75% during the forecast period from 2024 to 2030, to reach USD 14.64 billion by 2030. The demand for neuroprosthetics is primarily attributed to the growing prevalence of neurological disorders and nerve injuries and the rising number of patients suffering from hearing and vision loss. Increasing R&D activities and collaborations to develop advanced devices among key players are the key factors that are responsible in contributing to the positive growth of the neuroprosthetics market during the forecast period from 2024 to 2030.

Neuroprosthetics Market Dynamics:

The increasing prevalence of neurological disorders and nerve injuries is poised to drive significant growth in the neuroprosthetics market. According to data released by the World Health Organization (WHO) in April 2024, approximately 15.4 million people worldwide were living with spinal cord injuries in 2021. Similarly, the United Spinal Association reported in 2022 that around 17,700 individuals are diagnosed with spinal cord injuries annually in the United States. Neuroprosthetic devices, which restore motor function by stimulating muscles or nerves, have become crucial for individuals affected by such injuries. As the incidence of neurological conditions, especially spinal cord injuries, rises, so does the demand for neuroprosthetic solutions, accelerating market expansion.

The growing occurrence of motor neuron disorders, including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy, as well as cognitive disorders such as Alzheimer's and Parkinson's disease, is expected to further boost market growth. WHO estimates from 2023 show that approximately 55 million people worldwide were living with dementia, with nearly 10 million new cases being reported annually. Alzheimer's disease, the most common form of dementia, accounts for 60-70% of these cases. As the number of patients with motor neuron disorders continues to rise, the need for neuroprosthetics is projected to surge, driving substantial advancements in the market over the forecast period.

Furthermore, the demand for neuroprosthetics extends to sensory impairments, such as hearing and vision loss. WHO data from March 2023 indicates that over 190 million people in Europe were affected by hearing loss, a number expected to exceed 230 million by 2050. Cochlear implants, a leading type of neuroprosthetic device, play a key role in restoring hearing for individuals with severe sensorineural hearing loss by bypassing damaged parts of the inner ear and directly stimulating the auditory nerve. As hearing and vision impairments become more prevalent, the neuroprosthetics market is expected to experience robust growth.

Source: World Health Organization, 2023

In addition to rising patient numbers, increasing research and development initiatives are expected to fuel further market expansion. For example, in April 2021, Rice University and Houston Methodist launched the Center for Translational Neural Prosthetics, focusing on restoring brain functions lost due to disease or injury.

However, certain challenges, such as the high cost of these devices and the lack of proper training in underdeveloped regions, may constrain market growth. Addressing these barriers will be key to unlocking the full potential of neuroprosthetic technologies.

Neuroprosthetics Market Segment Analysis:

Neuroprosthetics Market by Type (Motor Prosthetics, Cognitive Prosthetics, Auditory Prosthetics/Cochlear Implants, and Visual Prosthetics/Retinal Implants), Procedure (Invasive and Non-Invasive), Technology (Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

The spinal cord stimulation (SCS) segment is expected to hold a prominent position in the neuroprosthetics market during the forecast period, driven by the rising prevalence of chronic pain conditions, including complex regional pain syndrome (CRPS) and spinal cord injuries. With an increasing number of patients affected by failed back syndrome and CRPS, demand for SCS technology is set to grow significantly. Research has consistently demonstrated that SCS is an effective treatment for managing patients with CRPS. According to 2023 data from the National Organization for Rare Disorders, approximately 200,000 individuals in the United States are affected by CRPS annually. As the prevalence of both CRPS and spinal cord injuries continues to rise, the demand for SCS devices is increasing, thereby contributing to substantial market growth.

Recent regulatory approvals for SCS technology are further expected to propel the neuroprosthetics market. For example, in April 2024, Medtronic received approval from the U.S. Food and Drug Administration (FDA) for its Inceptiv(TM) closed-loop rechargeable spinal cord stimulator, designed to treat chronic pain. This advanced device features a closed-loop system that senses biological signals along the spinal cord, ensuring consistent delivery of physician-prescribed stimulation for improved patient outcomes. Such technological advancements from key industry players are anticipated to drive continued growth in the market.

North America is expected to dominate the overall neuroprosthetics market:

North America is projected to dominate the global neuroprosthetics market during the forecast period, primarily driven by the rising prevalence of hearing loss and neurological disorders such as Alzheimer's disease, Parkinson's disease, and depression. Additionally, increasing healthcare awareness and ongoing technological advancements from leading industry players are significantly boosting market growth in this region.

A key factor driving market expansion in North America is the growing incidence of neurological disorders. According to a report from the Centers for Disease Control and Prevention (CDC) in September 2023, approximately 6.7 million individuals aged 65 and older in the United States were living with Alzheimer's disease, with that number expected to rise to 13.9 million by 2060. The escalating prevalence of such conditions is fueling demand for neuroprosthetic devices, thereby propelling market growth.

The growing burden of hearing loss is also contributing to the region's market expansion. CDC data from November 2023 revealed that in 2021, there were 6,520 reported cases of permanent hearing loss in the United States. This rising incidence is further driving the adoption of neuroprosthetic solutions, such as cochlear implants, to address sensory impairments.

Technological innovation by key players is another factor supporting North America's market dominance. For example, in November 2022, U.S.-based brain-computer interface company Blackrock Neurotech introduced Neuralace(TM), a next-generation neural interface. This advanced device, designed with diverse materials and patterns, connects with large areas of the brain's surface, enabling complex functions without the need for external assistive technologies. Neuralace offers groundbreaking solutions for vision and memory restoration, performance prediction, and the treatment of mental health disorders, underscoring the role of innovation in driving market growth.

Meanwhile, the Asia-Pacific region holds significant growth potential for the neuroprosthetics market. This expansion can be attributed to improving healthcare infrastructure, rising disposable incomes, and increasing incidences of hearing loss. According to a 2021 report from the World Health Organization (WHO), around 80% of people with disabling hearing loss reside in low- and middle-income countries, with over 25% of individuals aged 60 and older affected. As the region's economies develop and healthcare systems improve, the demand for neuroprosthetic devices is expected to rise, fueling further market growth in Asia-Pacific.

Neuroprosthetics Market Key Players:

Some of the key market players operating in the neuroprosthetics market include Medtronic, Boston Scientific Corporation, Abbott Laboratories, NeuroPace, Inc., Cochlear Ltd., Sonova, NeuroSigma, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., MED-EL Medical Electronics, BrainGate, NEVRO CORP., Terumo Corporation, Penumbra, Inc., BrainCo, Inc., Axoft Inc., Demant A/S, Synapse Biomedical Inc., Cognixion, Inc., and others.

Recent Developmental Activities in the Neuroprosthetics Market:

• In February 2024, Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) approved the WaveWriter(TM) SCS Systems for the treatment of chronic low back and leg pain. This system assists physicians in delivering individualized care for a broad range of lower back pain issues, allowing for tailored treatment strategies to address diverse patient needs.
• In January 2024, Abbott Laboratories announced that it granted FDA approval to market the Liberta RC(TM) DBS system. Liberta is the smallest rechargeable deep brain stimulation (DBS) device equipped with remote programming capabilities, designed to treat individuals with movement disorders such as Parkinson's disease and essential tremor.
• In March 2021, Second Sight Medical Products, a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, received the US Food and Drug Administration (FDA) approval for the Argus 2s Retinal Prosthesis System.
• In January 2021, Boston Scientific Corporation received FDA approval for its fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System used to treat symptoms in patients with advanced Parkinson's disease.

Key Takeaways from the Neuroprosthetics Market Report Study

• Market size analysis for current Neuroprosthetics Market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the Neuroprosthetics market.
• Various opportunities available for the other competitors in the Neuroprosthetics Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Neuroprosthetics market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Neuroprosthetics market growth in the coming future?

Target Audience who can be benefited from this Neuroprosthetics Market Report Study

• Neuroprosthetics product providers
• Research organizations and consulting companies
• Neuroprosthetics related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Neuroprosthetics
• Various end-users who want to know more about the Neuroprosthetics Market and the latest technological developments in the Neuroprosthetics Market.

Frequently Asked Questions for the Neuroprosthetics Market:

1. What are Neuroprosthetics?

• A neuroprosthetic is a kind of device that can ameliorate the input or output of a neural system. Neuroprosthetics encompass a variety of artificial devices or systems that can be used to enhance the motor, sensory, cognitive, visual, auditory, and communicative deficits that arise from acquired brain injuries.

2. What is the market for Neuroprosthetics?

• The Neuroprosthetics Market was valued at USD 7.14 billion in 2023, growing at a CAGR of 12.75% during the forecast period from 2024 to 2030 to reach USD 14.64 billion by 2030.

3. What are the drivers for the Neuroprosthetics market?

• The neuroprosthetics market is slated to witness prosperity owing to factors such as the growing prevalence of neurological disorders and nerve injuries and the rising number of patients suffering from hearing and vision loss. Increasing R&D activities and collaborations to develop advanced devices among key players are the key factors that are responsible for contributing to the positive growth of the neuroprosthetics market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Neuroprosthetics market?

• Some of the key market players operating in the neuroprosthetics market include Medtronic, Boston Scientific Corporation, Abbott Laboratories, NeuroPace, Inc., Cochlear Ltd., Sonova, NeuroSigma, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., MED-EL Medical Electronics, BrainGate, NEVRO CORP., Terumo Corporation, Penumbra, Inc., BrainCo, Inc., Axoft Inc., Demant A/S, Synapse Biomedical Inc., Cognixion, Inc., and others.

5. Which region has the highest share in the Neuroprosthetics market?

• North America is expected to dominate the overall neuroprosthetics market during the forecast period from 2024 to 2030. This dominance can be attributed to the rising prevalence of hearing loss and neurological disorders such as Alzheimer's disease, Parkinson's disease, and depression. Additionally, increasing healthcare awareness and technological innovations spearheaded by leading industry players are significantly contributing to market growth in North America.

Table of Contents

1. Neuroprosthetics Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Neuroprosthetics Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Neuroprosthetics Market Key Factors Analysis

• 5.1. Neuroprosthetics Market Drivers
  • 5.1.1. The growing prevalence of neurological disorders and nerve injuries
  • 5.1.2. Rising number of patients suffering from hearing and vision loss
  • 5.1.3. Increasing R&D activities and collaborations to develop advanced devices among key players
• 5.2. Neuroprosthetics Market Restraints and Challenges
  • 5.2.1. The high cost of these devices
  • 5.2.2. Lack of proper training in poor developed countries
• 5.3. Neuroprosthetics Market Opportunity
  • 5.3.1. Integration of robotic-assisted implantation
  • 5.3.2. Adoption of minimally invasive surgeries and smart implants

6. Neuroprosthetics Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Neuroprosthetics Market Assessment

• 7.1. By Type
  • 7.1.1. Motor Prosthetics
  • 7.1.2. Cognitive Prosthetics
  • 7.1.3. Auditory Prosthetics/Cochlear Implants
  • 7.1.4. Visual Prosthetics/Retinal Implants
• 7.2. By Procedure
  • 7.2.1. Invasive
  • 7.2.2. Non-Invasive
• 7.3. By Technology
  • 7.3.1. Deep Brain Stimulation
  • 7.3.2. Vagus Nerve Stimulation
  • 7.3.3. Sacral Nerve Stimulation
  • 7.3.4. Spinal Cord Stimulation
  • 7.3.5. Transcranial Magnetic Stimulation
  • 7.3.6. Others
• 7.4. By End-User
  • 7.4.1. Hospitals and Clinics
  • 7.4.2. Ambulatory Surgical Centers
  • 7.4.3. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. United States Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.1.2. Canada Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.1.3. Mexico Neuroprosthetics Market Size in USD million (2021-2030)
  • 7.5.2. Europe
    • 7.5.2.1. France Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.2.2. Germany Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.2.3. United Kingdom Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.2.4. Italy Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.2.5. Spain Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.2.6. Rest of Europe Neuroprosthetics Market Size in USD million (2021-2030)
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. China Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.3.2. Japan Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.3.3. India Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.3.4. Australia Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.3.5. South Korea Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.3.6. Rest of Asia-Pacific Neuroprosthetics Market Size in USD million (2021-2030)
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. Middle East Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.4.2. Africa Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.4.3. South America Neuroprosthetics Market Size In USD Million (2021-2030)

8. Neuroprosthetics Market Company and Product Profiles

• 8.1. Medtronic
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Boston Scientific Corporation
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Abbott Laboratories
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. NeuroPace, Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Cochlear Ltd.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Sonova
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. NeuroSigma, Inc.
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Blackrock Neurotech
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Synchron
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. LivaNova, Inc.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. MED-EL Medical Electronics
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. BrainGate
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. NEVRO CORP.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Terumo Corporation
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Penumbra, Inc.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. BrainCo, Inc.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Axoft Inc.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Demant A/S
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Synapse Biomedical Inc.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Cognixion, Inc.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us